Should VillageMD prioritize expanding its telemedicine services to reach more patients or focus on enhancing in-person clinic experiences for existing patients?

Introduction

The trade-off VillageMD faces is whether to prioritize expanding telemedicine services to reach more patients or focus on enhancing in-person clinic experiences for existing patients. This scenario involves balancing growth through digital channels with improving the core in-person offering. I'll analyze this trade-off by examining the business context, user impact, technical considerations, and resource implications to provide a strategic recommendation.

Step 1

Clarifying Questions (3 minutes)

• Based on VillageMD's current market position, I'm thinking telemedicine might be a relatively new offering. Could you share how long we've been providing telemedicine services and what percentage of our patient interactions are currently virtual?

Why it matters: Helps understand the maturity of our telemedicine offering and its current adoption rate. Expected answer: Telemedicine launched 1-2 years ago, currently 20-30% of interactions. Impact on approach: A newer service with lower adoption might lean towards expansion, while a mature service might focus on enhancement.

• Considering our revenue model, I'm assuming we have a mix of fee-for-service and value-based care contracts. How does the revenue split look between these models, and how might expanding telemedicine impact our ability to meet value-based care metrics?

Why it matters: Aligns the decision with our financial incentives and contractual obligations. Expected answer: 60% value-based care, 40% fee-for-service. Telemedicine could improve certain metrics like patient engagement and preventive care. Impact on approach: Higher value-based care percentage might favor telemedicine expansion for better patient engagement and outcomes.

• Looking at our patient demographics, I'm guessing we serve a diverse population. Can you provide insights into which patient segments are currently underserved or have shown the most interest in telemedicine?

Why it matters: Identifies potential growth areas and ensures we're meeting diverse patient needs. Expected answer: Younger professionals and rural patients show high interest, while elderly patients prefer in-person visits. Impact on approach: Would help tailor the expansion or enhancement strategy to specific user segments.

• From a technical standpoint, I'm curious about our current telemedicine platform's scalability. What's our current capacity, and what would be required to significantly expand our virtual visit capabilities?

Why it matters: Assesses the feasibility and potential costs of telemedicine expansion. Expected answer: Current platform can handle 2x current volume, major expansion would require infrastructure upgrades. Impact on approach: Low scalability might favor enhancing in-person experiences in the short term while planning for long-term telemedicine growth.

• Regarding our clinic staff, I'm wondering about their current workload and capacity to take on additional telemedicine responsibilities. How are our physicians and support staff currently split between in-person and virtual care?

Why it matters: Determines if we have the human resources to support expansion or if we need to focus on optimizing current operations. Expected answer: 80% in-person, 20% virtual, with some strain on staff managing both modalities. Impact on approach: High staff strain might suggest focusing on enhancing and optimizing current offerings before expansion.